For the Inventor, By the Inventor

Enter assignee name

Ridgefield, CT, United States of America

Thetis Pharmaceuticals LLC

USPTO Granted Patents = 14

% Expired Patents = 64.3

EPO Patents = 2

Forward Citations = 32

Loading Chart...

Loading Chart...

10 inventors (with patents filed for the assignee):

Frank C Sciavolino (14 out of 16 patents)

Gary Mathias (9 out of 10 patents)

Jessica J Dworak (5 out of 5 patents)

4. Banavara L Mylari (5 out of 9 patents)

5. Gunnar Erik Jagdmann, Jr (5 out of 11 patents)

6. Michael C Van Zandt (5 out of 44 patents)

7. Dipak Panigrahy (1 out of 2 patents)

8. Aaron Mathias (1 out of 1 patent)

9. John Parkinson (1 out of 1 patent)

10. Robert Lipper (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 12564644 - Cyclodextrin complexes of specialized proresolving mediators (2026-03-03),

2. 11986512 - Compositions and methods for cancer therapy (2024-05-21),

3. 11925688 - Compositions and methods relating to salts of specialized pro-resolving mediators (2024-03-12),

4. 11191840 - Compositions and methods relating to salts of specialized pro-resolving mediators (2021-12-07),

5. 11135298 - Compositions and methods relating to salts of specialized pro-resolving mediators (2021-10-05),

6. 10420843 - Compositions and methods relating to salts of specialized pro-resolving mediators (2019-09-24),

7. 10130719 - Compositions and methods relating to salts of specialized pro-resolving mediators (2018-11-20),

8. 9999626 - Mineral amino-acid complexes of active agents (2018-06-19),

9. 9382187 - Tri-salt form of metformin (2016-07-05),

10. 9242008 - Mineral amino-acid complexes of fatty acids (2016-01-26),

11. 9216951 - Lipid-lowering antidiabetic agent (2015-12-22),

12. 9012507 - Lipid-lowering antidiabetic agent (2015-04-21),

13. 8901107 - Lipid-lowering antidiabetic agent (2014-12-02),

14. 8765811 - Tri-salt form of metformin (2014-07-01),

Thetis Pharmaceuticals LLC, based in Ridgefield, CT, is a biopharmaceutical company focused on developing innovative therapies for unmet medical needs. The organization specializes in the research and development of novel drug candidates, particularly in the fields of oncology and autoimmune diseases. By leveraging advanced scientific methodologies and a commitment to improving patient outcomes, Thetis aims to bring transformative solutions to the healthcare landscape, addressing critical challenges in disease management.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

14 Patents

#5 in Ridgefield, CT

#497 in Connecticut

#22,302 in US

#42,199 in the World

Ridgefield, CT, United States of America

Thetis Pharmaceuticals LLC

Forward Citations = 32

10 inventors:

Frank C Sciavolino (14 out of 16 patents)

Gary Mathias (9 out of 10 patents)

Jessica J Dworak (5 out of 5 patents)

4. Banavara L Mylari (5 out of 9 patents)

5. Gunnar Erik Jagdmann, Jr (5 out of 11 patents)

Please report any incorrect information to [email protected]

Loading…